e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Late-Breaking Abstracts Session: New mechanisms in airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late-breaking abstract: Further studies on the mechanism of action of doxofylline
T. Jolas, C. Page, L. Allegra (Celle l‘Evescault, France; London, United Kingdom; Milan, Italy)
Source:
Annual Congress 2011 - Late-Breaking Abstracts Session: New mechanisms in airway disease
Session:
Late-Breaking Abstracts Session: New mechanisms in airway disease
Session type:
Oral Presentation
Number:
3414
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Jolas, C. Page, L. Allegra (Celle l‘Evescault, France; London, United Kingdom; Milan, Italy). Late-breaking abstract: Further studies on the mechanism of action of doxofylline. Eur Respir J 2011; 38: Suppl. 55, 3414
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Late-breaking abstract: Pre-clinical efficacy of RP5090 in PI3Kδ mediated airway disorders
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011
Late-breaking abstract: The effects of roxithromycin as anti-inflammatoy agent on clinical outcomes in patient with bronchiectasis: A double blinded randomized controlled study
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011
How pharmacokinetic/pharmacodynamic science informs dosage recommendations?
Source: Annual Congress 2010 - PG17 GRACE Postgraduate Course: Antimicrobial treatment of LRTI: important new aspects for clinical practice
Year: 2010
Late-breaking abstract: Once-daily NVA237 improves exercise endurance from first dose in patients with COPD: The GLOW3 trial
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011
Concept and pre-clinical studies
Source: Annual Congress 2010 - [italic]Ex vivo[/italic] graft evaluation and reconditionning in human lung transplantation
Year: 2010
Late-breaking abstract: Local and systemic distribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure
Source: Annual Congress 2011 - Late-Breaking Abstracts Session: New treatments and targets for airway disease
Year: 2011
What do qualitative studies teach us about physical activity in patients with COPD? A systematic review
Source: Annual Congress 2010 - Optimising the care and management of patients with COPD
Year: 2010
Challenges in IPF trials: the point on endpoints
Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions
Year: 2010
Placebo effects in pharmaceutical clinical trials in bronchiectasis: an EMBARC study
Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria
Year: 2020
Pragmatic controlled trial of azithromycin for asthma in adults
Source: Annual Congress 2011 - Phenotyping asthma: a clue for treatments?
Year: 2011
Late-breaking abstract: Sildenafil for chronic obstructive pulmonary disease: A randomized crossover trial
Source: Annual Congress 2011 - COPD: integrated care and rehabilitation
Year: 2011
Late Breaking Abstract - Objective physical activity as a clinical trial outcome in patients with COPD: a view on the literature from a task force of experts in the field
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019
The pre-clinical pharmacology of the inhaled muscarinic antagonist GSK573719 predicts once-daily clinical dosing
Source: Annual Congress 2011 - Understanding disease and drug mechanisms
Year: 2011
Late-breaking abstract: Pneumonia hospitalizations and long-term exposure to air pollution: A cohort study
Source: Annual Congress 2011 - Outdoor air pollution studies
Year: 2011
Late-breaking abstract: Wii Fit-step is a suitable exercise in rehabilitation programs in patients with COPD: A feasibility study
Source: Annual Congress 2011 - The best abstracts in rehabilitation and chronic care 2011 (sponsored by Nutricia Advanced Medical Nutrition)
Year: 2011
The EASE trial: rationale, study design and early results
Source: Annual Congress 2010 - Clinical Trials: "EURO VENT - endobronchial valves in heterogeneous emphysema patients", "EASE - randomized trial of airway bypass in homogeneous emphysema"
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept